The biotech sector assumes a crucial role in propelling the advancement of healthcare by spearheading the creation of innovative therapies and technologies aimed at addressing unmet medical requirements.
Against this backdrop, it could be wise to invest in fundamentally sound biotech stocks Gilead Sciences, Inc. (GILD), Biogen Inc. (BIIB), and Alkermes plc (ALKS), which are trading at a discount relative to their peers.
